News >

Expert Highlights Latest Advances, Next Steps in HER2+ Breast Cancer

Caroline Seymour
Published: Thursday, May 09, 2019

Joanne Mortimer, MD

Joanne Mortimer, MD

Data from the phase III KATHERINE trial in early HER2-positive breast cancer and smaller studies in the metastatic setting are shaping modern treatment models and testifying to the prospect of improved prognoses, explained Joanne Mortimer, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication
x